Nuclear Molecular Imaging

Bruker's molecular and nuclear imaging product portfolio was created to enable new discoveries and reveal more details about disease and therapeutics, while providing reproducible evidence.

By combining our novel PET, proven micro-CT and robust MRI technologies, we make translational multi-modal imaging more accessible to the research community and offering optimal solutions for laboratories. All while keeping in mind that software, animal handling and lab workflow is a key part of any laboratory.

Bruker's molecular imaging technologies opens the door to study a broad spectrum of applications for functional, structural and metabolic assessments.

PET combined with MR or CT

Bruker BioSpin has taken individual modalities and combined them to provide you with functional and morphological information. This combination means improved soft tissue contrast, cross validation of methods.

Simultaneous or Sequential PET/MR

Do you need simultaneous or sequential PET/MR? Bruker offers both, allowing you to choose the system best suited to your research and financial parameters.